A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ... FiercePharma: Lilly's Zepbound, Mounjaro show out with $10B quarter despite CVS formulary hitch Lilly's Zepbound, Mounjaro show out with $10B quarter despite CVS formulary hitch Yahoo: CVS dropped Zepbound in standard coverage.

Understanding the Context

What that means for Zepbound users CVS dropped Zepbound in standard coverage. What that means for Zepbound users Fierce Healthcare: CVS Caremark hit with class-action lawsuit over decision to drop Zepbound from formulary A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. Earlier this year, Caremark revealed that it would remove Eli Lilly's blockbuster drug ... CVS Caremark hit with class-action lawsuit over decision to drop Zepbound from formulary Forbes: CVS Dropping Zepbound: What It Means For Patients, Payers, And Pharma WGRZ: CVS opts for Wegovy over Zepbound, affecting drug access for some NEW YORK — CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1.

Key Insights

Zepbound ...